Achieve Life Sciences, Inc. Share-based Payment Arrangement, Expense
Achieve Life Sciences, Inc. (ACHV) reported Share-based Payment Arrangement, Expense of $2.20 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2013-08-08
- Achieve Life Sciences, Inc. share-based payment arrangement, expense for the quarter ending 2012-06-30 was $200.00K.
- Achieve Life Sciences, Inc. share-based payment arrangement, expense for fiscal 2012 was $2.20M, a 83.33% increase from fiscal 2011.
- Achieve Life Sciences, Inc. share-based payment arrangement, expense for fiscal 2011 was $1.20M, a 100.00% increase from fiscal 2010.
- Achieve Life Sciences, Inc. share-based payment arrangement, expense for fiscal 2010 was $600.00K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|
| 2012-12-31 | $2.20M 10-K · filed 2013-03-07 | ||
| 2012-06-30 | $200.00K 10-Q · filed 2013-08-08 | $200.00K 10-Q · filed 2013-08-08 | |
| 2011-12-31 | $1.20M 10-K · filed 2013-03-07 | ||
| 2010-12-31 | $600.00K 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |